These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1687401)
21. OC practice guidelines: minimizing side effects. Darney PD Int J Fertil Womens Med; 1997; Suppl 1():158-69. PubMed ID: 9168375 [TBL] [Abstract][Full Text] [Related]
22. [Pros and cons of triphasic oral contraception]. Berdah J Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular effects of oral contraceptives: a review. Stubblefield PG Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258 [TBL] [Abstract][Full Text] [Related]
24. Comparing the health risks and benefits of contraceptive choices. Kost K; Forrest JD; Harlap S Fam Plann Perspect; 1991; 23(2):54-61. PubMed ID: 2060612 [TBL] [Abstract][Full Text] [Related]
25. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
26. Weighing the evidence on the pill and breast cancer. Johnson JH Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859 [TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives in 1984. Chapler EK Iowa Med; 1984 Oct; 74(10):439-40, 442. PubMed ID: 6490338 [TBL] [Abstract][Full Text] [Related]
28. Oral contraceptives and cancer of the reproductive organs. Huezo C IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511 [TBL] [Abstract][Full Text] [Related]
29. [Oral contraception, glucid metabolism and monitoring criteria]. Gaspard U Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000 [TBL] [Abstract][Full Text] [Related]
30. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance. Lebrun CM Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042 [TBL] [Abstract][Full Text] [Related]
33. [Benefits and risks of hormonal contraception]. Tscherne G Gynakol Geburtshilfliche Rundsch; 1992; 32(3):174-6. PubMed ID: 1467664 [TBL] [Abstract][Full Text] [Related]
34. Oral contraceptives: Pt. 2. Family Planning Association of New South Wales Fam Plann Inf Serv; 1978; 1(2):1-36. PubMed ID: 12338652 [TBL] [Abstract][Full Text] [Related]
35. IPPF statement on oral contraceptives and cancer of the breast. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374 [TBL] [Abstract][Full Text] [Related]
36. Current perspectives on combination oral contraceptives. Smith MA; Youngkin EQ Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284 [TBL] [Abstract][Full Text] [Related]
37. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U; Dubois M Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [TBL] [Abstract][Full Text] [Related]
38. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives. Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497 [TBL] [Abstract][Full Text] [Related]
39. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism]. Belaisch J; Hommais-loufrani B Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001 [TBL] [Abstract][Full Text] [Related]